Experimental models of dermal fibrosis and systemic sclerosis

被引:13
|
作者
Avouac, Jerome [1 ]
Elhai, Muriel [1 ]
Allanore, Yannick [1 ]
机构
[1] Paris Descartes Univ, Cochin Hosp, Rheumatol Dept A, INSERM,U1016,CNRS,UMR8104,Cochin Inst, Paris, France
关键词
Systemic sclerosis; Animal models; Dermal fibrosis; VERSUS-HOST-DISEASE; MAST-CELL DEPLETION; LUNG FIBROSIS; MURINE MODEL; T-CELLS; SCLERODERMA; SKIN; DNA; ACTIVATION; RECEPTOR;
D O I
10.1016/j.jbspin.2012.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculopathy, immunological abnormalities, and fibrosis are the key features in the pathogenesis of systemic sclerosis (SSc). Expression of each of the three pathologic features varies among SSc patients leading to disease heterogeneity and variable organ manifestations. Although the etiology of SSc has not yet been fully elucidated, a growing body of evidence suggests that extracellular matrix overproduction by activated fibroblasts results from a complex interplay between endothelial cells, immune cells and fibroblasts through cell cell and cell matrix interactions and communications. Relevant animal models are essential tools to in-depth investigate pathogenesis of SSc. Several murine and avian models are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation. In addition, typical microvascular changes of SSc are only observed in few models. Therefore, none of these animal models encompasses all features of the human disease and a critical selection is mandatory for successful in vivo studies. Hence, we will provide an overview of the most important experimental models of dermal fibrosis and SSc and discuss their respective contribution to the better understanding of SSc pathogenesis. (c) 2012 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [21] Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis
    Ahmet Karatas
    Burak Oz
    Cigdem Celik
    Zeynel Abidin Akar
    Ramazan Fazil Akkoc
    Ebru Onalan Etem
    Adile Ferda Dagli
    Suleyman Serdar Koca
    Scientific Reports, 12
  • [22] Allogeneic marrow transplantation in patients with severe systemic sclerosis - Resolution of dermal fibrosis
    Nash, Richard A.
    McSweeney, Peter A.
    Nelson, J. Lee
    Wener, Mark
    Georges, George E.
    Langston, Amelia A.
    Shulman, Howard
    Sullivan, Keith M.
    Lee, Julie
    Henstorf, Gretchen
    Storb, Rainer
    Furst, Daniel E.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (06): : 1982 - 1986
  • [23] Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis
    Wu, Minghua
    Pedroza, Mesias
    Lafyatis, Robert
    George, Anuh-Teresa
    Mayes, Maureen D.
    Assassi, Shervin
    Tan, Filemon K.
    Brenner, Michael B.
    Agarwal, Sandeep K.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (04) : 1010 - 1021
  • [24] Therapeutic Effect of Cyclin-Dependent Kinase 4/6 Inhibitor on Dermal Fibrosis in Murine Models of Systemic Sclerosis
    Yamamoto, Akio
    Saito, Tetsuya
    Hosoya, Tadashi
    Kawahata, Kimito
    Asano, Yoshihide
    Sato, Shinichi
    Mizoguchi, Fumitaka
    Yasuda, Shinsuke
    Kohsaka, Hitoshi
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (05) : 860 - 870
  • [25] The Antifibrotic Effect of α2AP Neutralization in Systemic Sclerosis Dermal Fibroblasts and Mouse Models of Systemic Sclerosis
    Kanno, Yosuke
    Shu, En
    Kanoh, Hiroyuki
    Seishima, Mariko
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (04) : 762 - 769
  • [26] Fibrosis in systemic sclerosis
    Varga, John A.
    Trojanowska, Maria
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2008, 34 (01) : 115 - +
  • [27] FIBROSIS IN SYSTEMIC SCLEROSIS
    Varga, John
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S71 - S71
  • [28] Exploring the Link Between Atgl-Dependent Lipolysis and Dermal Fibrosis in Systemic Sclerosis
    Caves, Elizabeth
    Dixit, Agrani
    Jussila, Anna
    Lei, Vivian
    Edelman, Hailey
    Hamdan, Muhammad
    Odell, Ian
    Hinchcliff, Monique
    Atit, Radhika
    Horsley, Valerie
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1642 - 1644
  • [29] Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis
    Manetti, Mirko
    Romano, Eloisa
    Rosa, Irene
    Guiducci, Serena
    Bellando-Randone, Silvia
    De Paulis, Amato
    Ibba-Manneschi, Lidia
    Matucci-Cerinic, Marco
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (05) : 924 - 934
  • [30] MACITENTAN IN THE TREATMENT OF DERMAL FIBROSIS IN PATIENTS AFFECTED BY LIMITED SYSTEMIC SCLEROSIS: IN VITRO EVIDENCES
    Corallo, C.
    Pecetti, G.
    Iglarz, M.
    Montella, A.
    Nuti, R.
    Giordano, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S114 - S114